These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33489573)

  • 1. Cytomegalovirus-Associated Venous and Arterial Thrombotic Disease.
    Kelkar AH; Loc BL; Tarantino MD; Rajasekhar A; Wang H; Kelkar M; Farrell J
    Cureus; 2020 Dec; 12(12):e12161. PubMed ID: 33489573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis following acute cytomegalovirus infection: a community prospective study.
    Paran Y; Shalev V; Steinvil A; Justo D; Zimmerman O; Finn T; Berliner S; Zeltser D; Weitzman D; Raz R; Chodick G
    Ann Hematol; 2013 Jul; 92(7):969-74. PubMed ID: 23455402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitis.
    King C; Patel R; Mendoza C; Walker JK; Wu EY; Moss P; Morgan MD; O'Dell Bunch D; Harper L; Chanouzas D
    Arthritis Res Ther; 2022 Aug; 24(1):192. PubMed ID: 35948984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus infection is associated with venous thromboembolism of immunocompetent adults--a case-control study.
    Schimanski S; Linnemann B; Luxembourg B; Seifried E; Jilg W; Lindhoff-Last E; Schambeck CM
    Ann Hematol; 2012 Apr; 91(4):597-604. PubMed ID: 21913128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.
    Singh N; Winston DJ; Razonable RR; Lyon GM; Silveira FP; Wagener MM; Stevens-Ayers T; Edmison B; Boeckh M; Limaye AP
    JAMA; 2020 Apr; 323(14):1378-1387. PubMed ID: 32286644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological markers as indicators for congenital cytomegalovirus infection.
    Abo-Elwafa HA; Eldin SS; Sharaf AE; Abdelmonem AM
    Egypt J Immunol; 2010; 17(2):1-10. PubMed ID: 23082482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
    Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
    East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism associated with acute cytomegalovirus infection: epidemiology and predisposing conditions.
    Yildiz H; Zech F; Hainaut P
    Acta Clin Belg; 2016 Aug; 71(4):231-4. PubMed ID: 27141959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals. A systematic review.
    Ceccarelli M; Venanzi Rullo E; Nunnari G
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):381-390. PubMed ID: 29344839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cytomegalovirus in sensorineural hearing loss of children: a case-control study Tehran, Iran.
    Samileh N; Ahmad S; Mohammad F; Framarz M; Azardokht T; Jomeht E
    Int J Pediatr Otorhinolaryngol; 2008 Feb; 72(2):203-8. PubMed ID: 18054797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus shedding in seropositive healthy women of reproductive age in Tianjin, China.
    Ju D; Li XZ; Shi YF; Li Y; Guo LQ; Zhang Y
    Epidemiol Infect; 2020 Feb; 148():e34. PubMed ID: 32070447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation.
    Weir MR; Henry ML; Blackmore M; Smith J; First MR; Irwin B; Shen S; Genemans G; Alexander JW; Corry RJ
    Transplantation; 1988 Jan; 45(1):111-6. PubMed ID: 2827352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.
    Tong CY; Cuevas L; Williams H; Bakran A
    J Clin Microbiol; 1998 Sep; 36(9):2681-5. PubMed ID: 9705413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection.
    Torii Y; Yoshida S; Yanase Y; Mitsui T; Horiba K; Okumura T; Takeuchi S; Suzuki T; Kawada JI; Kotani T; Yamashita M; Ito Y
    BMC Pregnancy Childbirth; 2019 Jun; 19(1):205. PubMed ID: 31221131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time.
    Larsson S; Söderberg-Nauclér C; Wang FZ; Möller E
    Transfusion; 1998 Mar; 38(3):271-8. PubMed ID: 9563407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: a prospective study.
    Preiksaitis JK; Desai S; Vaudry W; Roberts S; Akabutu J; Grundy P; Wilson B; Boshkov L; Hannon J; Joffres M
    Transfusion; 1997 Sep; 37(9):941-6. PubMed ID: 9308642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan.
    Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kato S; Kasahara S; Iseki T; Yamaguchi T; Tojo A; Asano S
    Eur J Haematol; 2008 Mar; 80(3):251-7. PubMed ID: 18081702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic markers for cytomegalovirus in acute coronary syndromes.
    Timóteo A; Ferreira J; Paixão P; Aguiar C; Teles R; Cardoso E; Silva JA; Marques T; Seabra-Gomes R
    Rev Port Cardiol; 2003 May; 22(5):619-31. PubMed ID: 12940177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.